VivoSeq
Musculoskeletal

Adolescent Idiopathic Scoliosis

11

Pipeline Programs

6

Active Trials

2

Companies Involved

Adolescent Idiopathic Scoliosis is an emerging landscape with 11 programs across 2 companies. The most active players are McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc., Amring. 7 therapies are approved.

Pipeline Metrics

Competitive Density

41/100

Pipeline Velocity

22/100

Mech. Concentration

20/100

Completion Rate

60/100

Attrition Rate

9/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Programs by Phase

Trial Status

11

clinical trials

Completed3 · 27%
Recruiting3 · 27%
Not yet recruiting2 · 18%
Suspended1 · 9%
Terminated1 · 9%
Active, not recruiting1 · 9%

Trial Activity

11 trials

Kids With Iron Deficiency and Scoliosis (KIDS) Study
Recruiting·CColumbia University·Preclinical·NCT06042699·275 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)